2019 International Congress » Neuroimaging

Date: Wednesday, September 25, 2019

Time: 1:15pm-2:45pm

Location: Les Muses Terrace, Level 3

Meeting: 2019 International Congress

1:15pm-2:45pm: “Brain-first” vs. “body-first” Parkinson’s disease is determined by RBD-status – a multi-modality imaging study

J. Horsager, K. Knudsen, K. Andersen, C. Skjærbæk, T. Fedorova, J. Geday, J. Kraft, E. Bech, E. Danielsen, M. Møller, N. Pavese, D. Brooks, P. Borghammer (Aarhus N, Denmark)

1:15pm-2:45pm: 11C-PBB3 PET in PD: does alpha-synuclein pathology start in axonal terminals?

M. Matarazzo, A. Pérez-Soriano, V. Sossi, N. Vafai, E. Shahinfard, K. Ju-Chieh Cheng, J. Mckenzie, N. Neilson, Q. Miao, H. Shinotoh, M. Higuchi, A. Stoessl (Vancouver, BC, Canada)

1:15pm-2:45pm: 18F-DPA714 PET reveals neuroinflammatory activity in the Substantia nigra of patients with Parkinson disease

S. Lavisse, C. Wimberley, S. Goutal, M. Bottlaender, B. Kuhnast, MA. Peyronneau, M. Sarazin, P. Hantraye, C. Thiriez, P. Remy (Fontenay Aux Roses, France)

1:15pm-2:45pm: Acute unilateral involuntary movement in a patient with posterior reversible encephalopathy syndrome

P-Y. Chen (Taipei, Taiwan)

1:15pm-2:45pm: Aerobic exercise alters brain structure and function in Parkinson’s disease – a randomized controlled trial

M. Johansson, I. Cameron, N. Vander Kolk, N. de Vries, I. Toni, B. Bloem, R. Helmich (Nijmegen, Netherlands)

1:15pm-2:45pm: Age-related failure in compensatory mechanisms and its relation to the Parkinson phenotype: evidence from a SPECT study in early and late-onset PD

G. Palermo, D. Frosini, S. Giannoni, M. Giuntini, D. Volterrani, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

1:15pm-2:45pm: Amyloid load and cognitive decline in Parkinson’s disease: preliminary longitudinal findings

M. Stark, T. Melzer, D. Myall, R. Keenan, T. Pitcher, KL. Horne, L. Livingston, M. Macaskill, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)

1:15pm-2:45pm: Appropriateness of DAT Scan Ordering in a University Hospital Practice

Z. Togher, S. Fullam, J. Britton, J. Duignan, R. Killeen, S. O'Riordan, M. Hutchinson (Dublin 4, Ireland)

1:15pm-2:45pm: Are there associations between altered brain connectivity and dopaminergic medication in Parkinson’s disease patients with freezing of gait?

A. Potvin-Desrochers, A. Atri, C. Paquette (Montreal, QC, Canada)

1:15pm-2:45pm: Arterial spin labelling detects subcortical hypoperfusion in early drug-naïve patients with Parkinson’s disease

SP. Caminiti, G. Pagano, G. Dervenoulas, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Association between sleep disturbances in Parkinson’s disease and bioimaging

M. Nagai, T. Tsujii, R. Ando, Y. Yamanishi, S. Tada, Y. Hosokawa (Ehime, Japan)

1:15pm-2:45pm: Association of MRI-derived estimated brain age and cognitive ability in Parkinson’s disease

K-L. Horne, R. Shoorangiz, L. Livingston, S. Grenfell, M. Almuqbel, B. Young, M. Pascoe, M. Livingstone, M. Macaskill, D. Myall, T. Pitcher, T. Anderson, J. Dalrymple-Alford, T. Melzer (Chrsitchurch, New Zealand)

1:15pm-2:45pm: Automated Diagnosis of Idiopathic Parkinson’s Disease Using Deep Convolutional Neural Networks

YH. Sung, DH. Shin, EY. Kim (Incheon, Republic of Korea)

1:15pm-2:45pm: Automated Interpretation of FP-CIT-SPECT images based on Artificial Intelligence

M. Meier, J. Hammes, A. Drzezga, T. Dratsch, C. Kobe, D. Dos Santos, T. van Eimeren (Cologne, Germany)

1:15pm-2:45pm: Caudal posterior substantia nigra iron increases longitudinally in Parkinson’s disease

N. Bergsland, R. Zivadinov, F. Schweser, J. Hagemeier, D. Lichter, T. Guttuso, JR. (Buffalo, NY, USA)

1:15pm-2:45pm: Cerebellar Structural changes in Patients with Parkinson’s disease and Essential Tremor

A. Lopez, P. Trujillo, B. Landman, P. Hedera, D. Claassen (Nashville, TN, USA)

1:15pm-2:45pm: Changes in Neuromelanin MRI Signal in Parkinson’s Disease: A Longitudinal Study

R. Gaurav, L. Yahia-Cherif, G. Mangone, N. Pyatigorskaya, R. Valabregue, C. Ewenczyk, M. Hutchison, J. Corvol, M. Vidailhet, S. Lehéricy (Paris, France)

1:15pm-2:45pm: Characteristics of spontaneous brain activity in left- and right-onset Parkinson’s disease patients

K. Li, W. Su, H. Zhao, C. Li, X. Ma, B. Lou, M. Chen, H. Chen (Beijing, China)

1:15pm-2:45pm: Classify Parkinson’s Disease with Mild Cognitive Impairment: Machine Learning Approach

SS. Cho, C. Li, Y. Koshimori, J. Kim, L. Christopher, M. Dı´ez-Cirarda, M. Valli, A. Mihaescu, S. Houle, A. Strafella (Toronto, ON, Canada)

1:15pm-2:45pm: Clinical and DAT Imaging Characteristics of Participants with Scans without Evidence of Dopaminergic Deficit (SWEDDs): PPMI Cohort 2 year follow-up

K. Marek, T. Simuni, A. Siderowf, D. Lafontant, C. Caspell-Garcia, C. Coffey, B. Mollenhauer, C. Tanner, K. Kieburtz, L. Chahine, J. Seibyl (New Haven, CT, USA)

1:15pm-2:45pm: Clinical correlation between 99mTc-TRODAT-1 SPECT and parkinsonism

AC. Chen (Taichung, Taiwan)

1:15pm-2:45pm: Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease

T. Yousaf, G. Pagano, H. Wilson, B. Corcoran, G. Vivian, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Comparison of PDE10A and DAT expression as markers of disease burden in early Parkinson’s disease

G. Pagano, H. Wilson, T. Yousaf, F. Niccolini, N. Khan, D. Martino, R. Gunn, E. Rabiner, P. Piccini, T. Foltynie, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Composite UHDRS shows extensive spatial correlation with grey matter and white matter volume in Huntington’s disease gene carriers

C. Estevez-Fraga, E. Johnson, F. Rodrigues, P. Zeun, A. Durr, D. Langbehn, B. Leavitt, R. Roos, S. Gregory, R. Scahill, G. Rees, S. Tabrizi (London, United Kingdom)

1:15pm-2:45pm: Connectivity alterations in dopaminergic and cholinergic networks mediate cognitive performance in patients with Parkinson’s disease: a resting-state fMRI study

ER. de Natale, SP. Caminiti, Z. Chappell, T. Yousaf, H. Wilson, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Correlating subcortical structure and function in idiopathic Parkinson’s disease: A cross-sectional morphometric and [18F]-DOPA PET study

M. Rolinski, V. Sossi, A. Stoessl, C. Marshall, S. Gill, P. Clatworthy, A. Whone (Bristol, United Kingdom)

1:15pm-2:45pm: Cortical and subcortical atrophy in typical and variant Parkinson-plus syndromes: PROSPECT-M-UK study

N. Holland, S. Jones, J. Woodside, E. Jabbari, V. Chelban, A. Costantini, PN. Leigh, D. Burn, N. Pavese, A. Gerhard, C. Kobylecki, M. Hu, A. Church, J. Rohrer, H. Houlden, H. Morris, J. Rowe (Cambridge, United Kingdom)

1:15pm-2:45pm: Cortical cholinergic dysfunction correlates with microglial activation in the Substantia Innominata in patients with REM sleep behavior disorder

K. Stær, A. Iranzo, M. Stokholm, K. østergaard, M. Eroles, M. Otto, K. Svendsen, A. Pla, D. Vilas, J. Santamaria, A. Møller, C. Gaig, P. Borghammer, D. Brooks, E. Tolosa, N. Pavese (Aarhus N, Denmark)

1:15pm-2:45pm: Could we optimize the stimulation parameters setting of directional leads with a patient-specific imaging software in implanted parkinsonian patients?

AS. Rolland, N. Carriere, G. Touzet, L. Defebvre, N. Reyns, D. Devos, C. Moreau (Lille Cedex, France)

1:15pm-2:45pm: Decline in Neural Connectivity in Olfactory Spatial Attention: A Comparative Study in the Progression of Parkinson’s Disease

H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)

1:15pm-2:45pm: Decreased Cannabinoid Type 1 Receptor Density in Parkinson’s Disease: A [18F]FMPEP-d2 PET Study

A. Brück, H. Al-Abdulrasul, J. Tuisku, R. Ajalin, J. Hirvonen, J. Rinne (Turku, Finland)

1:15pm-2:45pm: Depressive Symptoms are Associated with Lower Locus Coeruleus Volumes in Parkinson’s disease

C. Farrell, G. Pagano, E. de Natale, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Diagnostic potential of automated diffusion imaging for the differential diagnosis of multiple system atrophy and Parkinson’s disease

F. Krismer, V. Beliveau, K. Seppi, G. Goebel, G. Wenning, E. Gizewski, W. Poewe, C. Scherfler (Innsbruck, Austria)

1:15pm-2:45pm: Different patterns of brain activity during lower limb movements in Parkinson’s disease patients with and without freezing of gait

N. Piramide, E. Sarasso, E. Canu, S. Galantucci, A. Tettamanti, MA. Volontè, M. Filippi, F. Agosta (Milan, Italy)

1:15pm-2:45pm: Differential diagnosis of Parkinsonian Syndromes – combining clinical and imaging data in a machine-learning approach

T. Meindl, Y. Li, A. Jochim, T. Mantel, A. Hapfelmeier, B. Haslinger (Munich, Germany)

1:15pm-2:45pm: Differentiating the substantia nigra pars compacta and ventral tegmental area in early-stage Parkinson’s disease using quantitative susceptibility mapping

P. Macdonald, E. Alushaj, N. Handfield-Jones, A. Khan, A. Owen (London, ON, Canada)

1:15pm-2:45pm: Disrupted Functional Brain Connectome in Parkinson’s Disease Patients with Freezing of Gait

N. Li, L. Wang, X. Suo, J. Li, J. Peng, J. Zhang, R. Peng (Chengdu, China)

1:15pm-2:45pm: Disrupted salience network dynamics in Parkinson´s disease patients with impulse control disorders

I. Navalpotro-Gomez, J. Kim, PM. Paz-Alonso, M. Delgado-Alvarado, A. Quiroga-Varela, H. Jimenez-Urbieta, M. Carreiras, AP. Strafella, MC. Rodriguez-Oroz (San Sebastian, Spain)

1:15pm-2:45pm: Distributed Global Functional Connectivity Networks Predict Responsiveness to L-DOPA and Subthalamic Deep Brain Stimulation

C. Wu, T. Foltynie, P. Limousin, L. Zrinzo, H. Akram (Philadelphia, PA, USA)

1:15pm-2:45pm: Does Physical Activity impact Resting State Functional Connectivity in Parkinson Disease Patients?

R. Guimarães, A. Vieira, B. Campos, L. Piovesana, P. Azevedo, J. Zuiani, A. D'Abreu, F. Cendes (Campinas, Brazil)

1:15pm-2:45pm: Dopaminergic imaging in patients with basal ganglia calcification presenting with parkinsonism

A. Planas-Ballvé, N. Caballol, M. Balagué, E. Peral, L. Cano, X. Cardona, L. Vila, A. ávila (Sant Joan Despí, Spain)

1:15pm-2:45pm: Dual-task in Parkinson’s disease: a gait analysis and functional MRI study

E. Sarasso, A. Gardoni, S. Galantucci, A. Tettamanti, MA. Volontè, M. Filippi, F. Agosta (Milan, Italy)

1:15pm-2:45pm: Dynamic functional connectivity signature of cognitive decline in Parkinson’s disease

E. Fiorenzato, A. Strafella, J. Kim, R. Schifano, L. Weis, A. Antonini, R. Biundo (Venice, Italy)

1:15pm-2:45pm: Effective deep brain stimulation co-modulate cross-frequency coupling

S. Groppa, M. Glaser, N. Koirala, M. Bange, M. Muthuraman (Mainz, Germany)

1:15pm-2:45pm: Evaluating Volume Changes in the Substantia Nigra Pars Compacta (SNc) in Parkinson’s Disease (PD) in a Study-Specific Magnetic Resonance Imaging (MRI) Template

E. Biondetti, R. Gaurav, L. Yahia-Cherif, G. Mangone, N. Pyatigorskaya, R. Valabregue, C. Ewenczyk, M. Hutchison, JC. Corvol, MJ. Vidailhet, S. Lehéricy (Paris, France)

1:15pm-2:45pm: Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Huntington’s Disease: An in vivo [11C]BU99008 PET study

H. Wilson, F. Niccolini, G. Dervenoulas, R. Tyacke, J. Myers, R. Gunn, D. Nutt, E. Rabiner, S. Tabrizi, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Evaluation of Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson’s Disease: An in vivo [11C]BU99008 PET study

H. Wilson, G. Dervenoulas, G. Pagano, R. Tyacke, J. Myers, R. Gunn, E. Rabiner, D. Nutt, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Evidence of altered Serotonergic Network in Parkinson’s disease by using a multi-modal MRI and PET imaging approach

SP. Caminiti, Z. Chappell, A. Carotenuto, G. Dervenoulas, T. Yousaf, G. Pagano, H. Wilson, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT study

A. Pilotto, F. Schianodicola, E. Premi, R. Grasso, R. Turrone, S. Gipponi, A. Scalvini, E. Cottini, B. Pagherà, V. Garibotto, MC. Rizzetti, L. Bonanni, B. Borroni, S. Morbelli, F. Nobili, UP. Guerra, D. Perani, A. Padovani (Brescia, Italy)

1:15pm-2:45pm: FDG PET: a good predictive tool for CNS inflammation

M. Nader, F. Fluchere, T. Witjas, A. Eusebio, JP. Azulay (Marseille, France)

1:15pm-2:45pm: Focus on the Locus: Ultra-high field MRI evaluation of locus coeruleus structure and function in Parkinson’s Disease

C. Madelung, D. Meder, A. Løkkegaard, H. Siebner (Hvidovre, Denmark)

1:15pm-2:45pm: Fractional anisotropy patterns in non-demented Parkinson’s disease patients using hierarchical cluster analysis

H. Erostarbe, A. Inguanzo, R. Sala, A. Abos, A. Campabadal, C. Uribe, H. Baggio, Y. Compta, M. Marti, F. Valldeoriola, C. Junque, B. Segura (Barcelona, Spain)

1:15pm-2:45pm: Freezing of gait in Parkinson’s disease: a review of current neuroimaging evidence for the development of effective therapies

A. Potvin-Desrochers, C. Paquette (Montreal, QC, Canada)

1:15pm-2:45pm: Frequency-dependent abnormalities of intrinsic brain activity in Parkinson´s disease

L. Krajcovicova, R. Marecek, I. Rektorova (Brno, Czech Republic)

1:15pm-2:45pm: Functional Biomarkers of Parkinson’s Disease: Changes in Brain-Wide Network Connectivity in Default Mode and Fronto-Parietal Control Networks

P. Macdonald, N. Hiebert, L. Naci, A. Owen (Dublin, Ireland)

1:15pm-2:45pm: Functional brain connectome in drug-naïve Parkinson’s disease patients

R. de Micco, F. Agosta, S. Basaia, M. Siciliano, C. Cividini, G. Tedeschi, A. Tessitore, M. Filippi (Naples, Italy)

1:15pm-2:45pm: Functional connectivity within the cerebellum and brainstem in essential tremor patients– a tailored resting state fMRI approach

S. Sharifi, ES. Scheijbeler, WVP. Potters, AFR. Rootselaar (Amsterdam, Netherlands)

1:15pm-2:45pm: Functional connectome in Parkinson’s disease mild cognitive impairment

M. Delgado-Alvarado, V. Ferrer-Gallardo, I. Navalpotro-Gómez, S. Moia, M. Carreiras, C. Caballero-Gaudes, MC. Rodríguez-Oroz (Torrelavega, Spain)

1:15pm-2:45pm: Functional magnetic-resonant imaging in child cerebral palsy with epilepsy

D. Aminova, K. Aminov (Tashkent, Uzbekistan)

1:15pm-2:45pm: Functional MRI activation during the Symbol Digit Modalities Test in Parkinson’s disease

G. Grolez, R. Viard, R. Lopes, JP. Pruvo, K. Dujardin, L. Defebvre, C. Moreau (Lille, France)

1:15pm-2:45pm: Genotype influences circuit compensation in Parkinson’s disease

K. Schindlbeck, A. Vo, N. Nguyen, C. Tang, M. Niethammer, V. Dhawan, V. Brandt, R. Saunders-Pullman, S. Bressman, D. Eidelberg (Manhasset, NY, USA)

1:15pm-2:45pm: Glymphatic system activity in Parkinson’s disease: diffusion tensor image analysis along the perivascular space (DTI‑ALPS)

JM. Kim, YJ. Bae (Seongnam, Republic of Korea)

1:15pm-2:45pm: Gray Matter Abnormalities in Parkinson’s disease: a Voxel-wise meta-analysis

XR. Xu, Q. Han, JY. Lin, L. Wang, HF. Shang (Chengdu, China)

1:15pm-2:45pm: Gray matter substrates of depression in blepharospasm

J. Yang, YB. Hou, QQ. Wei, RW. Ou, W. Song, B. Cao, HF. Shang (Chengdu, China)

1:15pm-2:45pm: Grey matter atrophy in Parkinson’s disease with long-duration response

G. Donzuso, G. Sciacca, G. Mostile, A. Nicoletti, M. Zappia (Catania, Italy)

1:15pm-2:45pm: Hemispheric Differences in Motor Circuitry of Parkinson’s disease: Metabolism and Micro-Structure

DAN. Stein, N. Goldberg, L. Domachevsky, H. Bernstine, M. Nidam, D. Groshar, M. Lorberboym, S. Israeli-Korn, M. Gomori, Y. Assaf, S. Hassin-Baer (Tel-Aviv, Israel)

1:15pm-2:45pm: Humming bird sign in craniovertebral junction anomaly leading to misdiagnosis of progressive supranuclear palsy

D. Desai, D. Pandya, S. Desai (Anand, India)

1:15pm-2:45pm: Identification and Characterization of Selective and High Affinity Small Molecules as Positron Emission Tomography (PET) Imaging Tracers for Pathological Alpha-Synuclein

E. Tsika, E. Vokali, J. Molette, M. Ravache, P. Rodriguez, V. Darmency, K. Piorkowska, S. Poli, H. Kroth, F. Capotosti, D. Lowe, J. Stoehr, M. Kosco-Vilbois, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

1:15pm-2:45pm: Identifying altered resting state network connectivity in Parkinson’s disease with mild cognitive impairment

J. Yang, K. Mcmahon, D. Copland, G. Byrne, J. O'Sullivan, N. Dissanayaka (Herston, Australia)

1:15pm-2:45pm: Imaging biomarker for progression of motor symptoms in advanced Parkinson’s disease

K. Furukawa, N. Sawamoto, A. Shima, D. Kambe, A. Nishida, I. Wada, H. Sakamaki, K. Yoshimura, Y. Fushimi, T. Okada, K. Togashi, R. Takahashi (Kyoto, Japan)

1:15pm-2:45pm: Imaging Brain Insulin Resistance in Parkinson’s Disease using [¹⁸F]FDG-PET

E. Hogg, P. Linesch, T. Wu, E. Tan, Z. Fan, W. Gao, A. Waxman, M. Tagliati (Los Angeles, CA, USA)

1:15pm-2:45pm: Imaging correlates of impaired self-awareness of cognitive deficits in Parkinson’s disease

F. Maier, A. Greuel, M. Hoock, M. Tahmasian, F. Jessen, I. Csoti, L. Timmermann, C. Eggers (Cologne, Germany)

1:15pm-2:45pm: Impaired cerebral vasoreactivity in patients with Parkinson’s disease: clinical and imaging correlates

I. Estrada-Bellmann, D. Cantú-García, S. Castillo-Torres, A. Mendoza-García, H. Sánchez-Terán, D. Díaz-Pérez, D. Roque-Martínez, S. Saldívar-Dávila, H. Martínez, T. Moreno-Andrade, B. Chávez-Luévanos, F. Góngora-Rivera (Monterrey, NL, Mexico)

1:15pm-2:45pm: In vivo increased striatal iron deposition in Parkinson’s Disease Dementia and Dementia with Lewy Body

S. Rota, T. Yousaf, H. Wilson, G. Dervenoulas, G. Pagano, D. Aarsland, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Incidental iron deposition in basal ganglia: does the pattern matter? Fifteen years’ experience in a tertiary care center.

á. Beltrán Corbellini, P. Pérez Torre, A. Alonso Cánovas, F. Rodríguez Jorge, JL. Chico García, P. Parra Díaz, E. Natera Villalba, A. Gómez López, S. Fanjul Arbos, JL. López Sendón, JC. Martínez Castrillo, I. Parées Moreno (Madrid, Spain)

1:15pm-2:45pm: Increased fractional anisotropy in precuneus in Parkinson’s disease without mild cognitive impairment – a diffusion tensor imaging study

A. Nagano-Saito, J. Houde, C. Bedetti, M. Côté, O. Monchi (Montreal, QC, Canada)

1:15pm-2:45pm: Increased hub function in posterior medial cortex in Parkinson’s disease without mild cognitive impairement – A resting state fMRI study –

A. Nagano-Saito, P. Bellec, S. Jobert, B. Mejia-Constain, C. Degroot, A. Lafontaine, A. Hanganu, J. Lissemore, K. Smart, C. Benkelfat, O. Monchi (Montreal, QC, Canada)

1:15pm-2:45pm: Integrity of Mirror Neuron System in cervical dystonia: an fMRI study

A. Castagna, S. Di Tella, V. Blasi, M. Cabinio, F. Baglio (Milano, Italy)

1:15pm-2:45pm: Investigation of 531 cases of neuromelanin sensitive imaging, about its characteristics by disease

K. Matsuura, Y. Ii, M. Maeda, K. Tabei, M. Umino, H. Tomimoto (Tsu, Japan)

1:15pm-2:45pm: Is 18F-FDG-PET/CT a helpful tool to diagnose PSP clinical variants?

G. Marti-Andres, M. Riverol-Fernandez, R. Valentí-Azcárate, M. Fernández-Matarrubia, E. Prieto-Azcárate, J. Arbizu-Azcarate, MR. Luquin-Piudo (Pamplona, Spain)

1:15pm-2:45pm: Is awake physiological confirmation necessary for DBS treatment of Parkinson’s disease today? A comparison of intraoperative imaging, physiology, and physiology imaging-guided DBS in the past decade

GH. Lu, ZX. Yin, YY. Luo, YW. Jin (Nanchang, China)

1:15pm-2:45pm: Is DAT imaging abnormality in Normal Pressure Hydrocephalus always suggestive of degeneration? Evidences from three cases

C. Del Gamba, A. Bruno, D. Frosini, D. Volterrani, N. Benedetto, C. Pacchetti, P. Perrini, M. Cosottini, U. Bonuccelli, R. Ceravolo (Pisa, Italy)

1:15pm-2:45pm: Long-term changes in myocardial sympathetic innervation and function in synucleinopathies

G. Lamotte, C. Holmes, T. Wu, D. Goldstein (Bethesda, MD, USA)

1:15pm-2:45pm: Longitudinal Analysis of the Corticospinal tract microstructure in Parkinson’s Disease Patients

R. Guimarães, L. Piovesana, P. Azevedo, B. Campos, F. Cendes (Campinas, Brazil)

1:15pm-2:45pm: Longitudinal Change of Substantia Nigra Hyperechogenicity in Parkinson’s Disease Cohort

T. Toomsoo, I. Rubanovits, R. Kerner, T. Asser, M. Vähi, P. Taba (Tallinn, Estonia)

1:15pm-2:45pm: Measuring disease progression with neuroimaging in MSA-a systematic review

B. Heim, F. Krismer, W. Poewe, K. Seppi (Innsbruck, Austria)

1:15pm-2:45pm: Metabolic network abnormalities in drug-naive Parkinson’s disease

O. Lucas-Jimenez, K. Schindlbeck, C. Tang, S. Morbelli, D. Arnaldi, M. Pardini, M. Pagani, F. Nobili, D. Eidelberg (Bilbao, Spain)

1:15pm-2:45pm: Micro structural Changes in Substantia Nigra are associated with Severity of Parkinson’s Disease.

A. Safai, S. Rane, S. Prasad, J. Saini, P. Pal, M. Ingalhalikar (Pune, India)

1:15pm-2:45pm: Midbrain Atrophy in Patients with Preclinical Progressive Supranuclear Palsy

JH. Ahn, M. Kim, J. Youn, JS. Kim, JK. Mun, PH. Lee, SB. Koh, TB. Ahn, JW. Cho (Seoul, Republic of Korea)

1:15pm-2:45pm: Mitochondrial Complex 1, Sigma 1 Receptor and Synaptic Vesicle protein 2A density in early de novo patients with Parkinson’s Disease: pilot PET data

G. Pagano, H. Wilson, A. Mansur, S. Caminiti, R. Comley, H. Tsukada, R. Gunn, E. Rabiner, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Molecular correlates of survival and clinical severity in Progressive Supranuclear Palsy

M. Malpetti, L. Passamonti, T. Rittman, P. Vázquez Rodríguez, W R. Bevan-Jones, F I. Aigbirhio, J T. O'Brien, J B. Rowe (Cambridge, United Kingdom)

1:15pm-2:45pm: Motor Networks in Tremor-Dominant Parkinson’s Disease. A resting-state functional MRI and diffusion tensor imaging analysis.

Z. Chappell, H. Wilson, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Motor Symptoms in Typical Brain Aging

J. Zitser, K. Casaletto, A. Staffaroni, C. Sexton, A. Wolf, J. Brown, B. Miller, J. Kramer (San Francisco, CA, USA)

1:15pm-2:45pm: Multi-modal MRI in patients with genetically confirmed familial cortical myoclonic tremor with epilepsy type 1

F. Xie, B. Wang, J. Wang, Z. Cen, W. Wei, Y. Chen, H. Sun, D. Yang, Y. Lou, X. Chen, S. Chen, H. Wang, L. Wang, S. Wang, X. Qiu, Y. Ding, H. Yin, S. Wu, B. Zhang, Y. Zang, W. Luo (Hangzhou, China)

1:15pm-2:45pm: Multimodal Graph Theory Analysis Identifies Reward Network in Prediction of Motor Response to Deep Brain Stimulation

J. Muller, L. Li, C. Matias, M. Alizadeh, J. Miao, S. Thalheimer, V. Romo, F. Mohamed, C. Wu (Philadelphia, PA, USA)

1:15pm-2:45pm: Multimodal PET and fcMRI reveals regional modulation by STN DBS correlating to motor outcomes

J. Younce, A. Tanenbaum, M. Campbell, J. Perlmutter, S. Norris (St Louis, MO, USA)

1:15pm-2:45pm: Neural correlates of compensatory process and impaired working memory in Parkinson’s disease during disease progression

T. Hattori, R. Reynolds, S. Horovitz, G. Chen, C. Lungu, E. Wassermann, M. Hallett (Tokyo, Japan)

1:15pm-2:45pm: Neural correlates of visual cues for gait impairment in Parkinson’s disease: a preliminary analysis

S. Stuart, J. Wagner, S. Makeig, M. Mancini (Portland, OR, USA)

1:15pm-2:45pm: Neuroanatomical and Electrocortical Networks correlates in Parkinson’s Disease Patients with Mild Cognitive Impairment:The PaCoS Study

G. Donzuso, G. Giuliano, R. Monastero, R. Baschi, G. Mostile, A. Luca, C. Cicero, M. Zappia, A. Nicoletti (Catania, Italy)

1:15pm-2:45pm: Neuroanatomical correlates of early cognitive change in Parkinson’s disease

E. Bunting, L-A. Leyland, R. Weil (London, United Kingdom)

1:15pm-2:45pm: Neurofeedback-guided motor imagery in Parkinson’s disease

S. Tinaz, M. Elfil, J. Lemere, S. Basu, R. Sinha, D. Scheinost, M. Hampson (New Haven, CT, USA)

1:15pm-2:45pm: Neuroimaging in Parkinson’s disease dementia: Connecting the dots

R. Weil, J. Hsu, R. Darby, L. Soussand, M. Fox (Nashville, TN, USA)

1:15pm-2:45pm: NEURONAL NETWORK UNDERLYING DYSPHAGIA IN PARKINSON’S DISEASE

S. Polychronis, G. Pagano, VC. Suarez Contreras, T. Yousaf, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Neuronal Network Underlying Speech Difficulties in Parkinson’s Disease

S. Polychronis, G. Pagano, VC. Suarez Contreras, T. Yousaf, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Neuroradiological differences between patients with akinesia-dominant and tremor-dominant Parkinson’s disease

KO. Ohta, TN. Nakajima (Kashiwazaki, Japan)

1:15pm-2:45pm: No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson’s disease

E. Honkanen, L. Saari, K. Orte, M. Gardberg, T. Noponen, J. Joutsa, V. Kaasinen (Turku, Finland)

1:15pm-2:45pm: Occurrence of brain capillary dysfunction in patients with REM sleep behavior disorder

S. Eskildsen, A. Iranzo, M. Stokholm, K. Stær, K. østergaard, M. Eroles, M. Otto, K. Svendsen, A. Pla, D. Vilas, P. Borghammer, J. Santamaria, A. Møller, C. Gaig, D. Brooks, E. Tolosa, L. østergaard, N. Pavese (Aarhus N, Denmark)

1:15pm-2:45pm: Opposing effects of levodopa on basal ganglia activity in Parkinson’s disease during motion and rest

R. Jech, S. Holiga, F. Růžička, H. Möller, J. Roth, M. Schroeter, E. Růžička, K. Mueller (Prague, Czech Republic)

1:15pm-2:45pm: Patterns of brain activity linked to Mild Behavioral Impairment in Parkinson’s disease

EJ. Yoon, Z. Ismail, M. Kibreab, T. Hammer, J. Cheetham, I. Kathol, M. Ramezani, S. Lang, J. Sarna, D. Martino, S. Furtado, O. Monchi (Calgary, AB, Canada)

1:15pm-2:45pm: Patterns of cortical thickness, surface area and subcortical volume in Parkinson’s disease patients with freezing of gait

T. Mi, S. Garg, A. Liu, P. Chan, M. Mckeown (Beijing, China)

1:15pm-2:45pm: Peculiarities of the indicators of MR-diffusion in children’s cerebral palsy with symptomatic epilepsy

K. Aminov (Tashkent, Uzbekistan)

1:15pm-2:45pm: Periventricular hyperintensities and axial symptom of Parkinson’s disease

J. Ko, Y. Lee, MK. Sunwoo, JH. Yoon, SY. Kang, JY. Hong (Wonju, Republic of Korea)

1:15pm-2:45pm: Phosphodiesterase 10A and cognition in Parkinson’s disease

Z. Chappell, G. Pagano, H. Wilson, F. Niccolini, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Ponto-cortical aberrations:Neural correlations for Hypomimia in PD

P. Singru, V. Vadiyala, E. Ganesh, V. Vinodhanand (Georgetown, Guyana)

1:15pm-2:45pm: Postural and kinetic tremor is associated with pallidal dopamine denervation in patients with Parkinson’s disease

N. Choi, KW. Park, SH. Hong, CS. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Potential involvement of the caudate nucleus in GBA-associated Parkinson’s disease

MC. Ruppert, A. Greuel, M. Tahmasian, F. Maier, T. van Eimeren, K. Lohmann, L. Timmermann, M. Tittgemeyer, A. Drzezga, C. Eggers (Marburg, Germany)

1:15pm-2:45pm: Pre-frontal activation during walking in Parkinson’s disease: the impact of attention

S. Stuart, A. Giritharan, J. Quinn, M. Mancini (Portland, OR, USA)

1:15pm-2:45pm: Preserved white matter microstructure in Parkinson’s disease patients with levodopa-induced dyskinesia: Evaluation by neurite orientation dispersion and density imaging (NODDI)

T. Ogawa, T. Hatano, H. Takeshige, C. Andica, K. Kamagata, A. Saito, T. Koinuma, R. Nakamura, H. Iwamuro, G. Oyama, Y. Shimo, A. Umemura, M. Ito, S. Aoki, N. Hattori (Tokyo, Japan)

1:15pm-2:45pm: Primary disruption of the subsystems of the default mode network in drug-naïve Parkinson’s disease with mild cognitive impairments: a resting-state functional connectivity MRI study

YB. Hou, QQ. Wei, RW. Ou, J. Yang, W. Song, QY. Gong, HF. Shang (Chengdu, China)

1:15pm-2:45pm: Probabilistic tractography study of the nigrostriatal pathway in Parkinson’s disease

S. Tagliente, H. Wilson, Z. Chappell, T. Yousaf, E. de Natale, G. Pagano (London, United Kingdom)

1:15pm-2:45pm: Probing Error Signals of Postural Control in Fragile X Premutation carriers

C. O'Keeffe, M. Carro Domínguez, E. O'Rourke, N. Feerick, T. Lynch, R. Reilly (Dublin, Ireland)

1:15pm-2:45pm: Progression of dopaminergic and serotonergic dysfunction related to motor and nonmotor manifestations in apathetic and non-apathetic parkinsonian patients: a 4-year longitudinal double-tracer PET study

S. Prange, E. Metereau, H. Klinger, E. Schmitt, E. Lhommée, A. Bichon, D. Le Bars, A. Maillet, P. Pellissier, S. Meoni, E. Broussolle, A. Castrioto, P. Krack, S. Thobois (Bron, France)

1:15pm-2:45pm: Quantitative Susceptibility Mapping: an Biomarker for Diagnosis of Parkinson’s Disease and Evaluation Patients’ Condition

LX. Xue, EH. Xu, JK. Li, Q. Yang, P. Chan (Beijing, China)

1:15pm-2:45pm: Regional subcortical volumes predict gait decline in early Parkinson’s disease

J. Wilson, R. Lawson, B. Galna, A. Yarnall, S. Lord, R. Morris, L. Alcock, G. Duncan, T. Khoo, D. Burn, L. Rochester, J-P. Taylor (Newcastle Upon Tyne, United Kingdom)

1:15pm-2:45pm: Registration Algorithm of DBS Preoperative Image and ICBM-152 Atlas

H. Zheng, S. Luo, S. Cao, D. Huang, C. Xu (Nanjing, China)

1:15pm-2:45pm: Relations of clinical symptoms with dopamine transporter imaging in untreated Parkinson’s disease

Y. Mito, H. Yaguchi, Y. Tajima (Sapporo, Japan)

1:15pm-2:45pm: Relationship between serum uric acid and the pattern of striatal dopamine depletion in De Novo Parkinson’s disease

K. Baik, Y. Lee, S. Chung, H. Yoo, J. Jung, P. Lee (Seoul, Republic of Korea)

1:15pm-2:45pm: Relationship between striatal dopamine depletion and various non-motor symptoms in non-demented patients with Parkinson’s disease: a pilot study

JY. Lee, H. Ju, K. Im, MY. Ahn, KY. Kwon (Seoul, Republic of Korea)

1:15pm-2:45pm: Relationship between symptoms and regional density of metabotropic glutamate receptors subtype 1 measured with 11C-ITMM PET in de novo Parkinson’s disease

K. Ishiwata, K. Kimura, MR. Zhang, J. Toyohara, K. Wagatsuma, M. Sakata, K. Ishibashi, K. Ishii, M. Suzuki, M. Mishina (Kawasaki, Japan)

1:15pm-2:45pm: Relative Preservation of Serotonergic Function Increases Response to Treatment in Early PD

J. Fu, M. Matarazzo, I. Klyuzhin, K. Cheng, C. Bevington, J. Mckenzie, N. Heffernan, E. Shahinfard, M. Mckeown, AJ. Stoessl, V. Sossi (Vancouver, BC, Canada)

1:15pm-2:45pm: Resting state Functional Connectivity differences in Pediatric Patients with Tourette syndrome and Obsessive-compulsive disorder

S. Tikoo, F. Cardona, S. Tommasin, C. Giannì, N. Upadhyay, K. Bharti, G. Conte, G. Mirabella, A. Suppa, P. Pantano (Roma, Italy)

1:15pm-2:45pm: Retinal layer thinning in de novo Parkinson’s disease

A. Chrysou, N. Jansonius, T. van Laar (Groningen, Netherlands)

1:15pm-2:45pm: Role of clinical neuroimaging in X-linked dystonia-parkinsonism

J. Junker, A. Neumann, R. Rosales, D. Jamora, C. Diesta, J. Prasuhn, T. Muente, C. Klein, P. Schramm, N. Brueggemann (Luebeck, Germany)

1:15pm-2:45pm: Sleep Disturbances in Essential Tremor: A pilot investigation of the related brain microstructural changes using diffusion tensor imaging

YIL. Sengul, HAF. Otcu, ISM. Ustun, HAK. Sengul, ALP. Alkan (Istanbul, Turkey)

1:15pm-2:45pm: Structural and functional MRI brain alterations of Lewy body diseases

O. Lucas-Jiménez, N. Ibarretxe-Bilbao, N. Ojeda, J. Peña, A. Cabrera-Zubizarreta, A. Murueta-Goyena, JC. Gómez-Esteban, I. Gabilondo (Bilbao, Spain)

1:15pm-2:45pm: Structural changes in non-manifesting GBA mutation carriers and GBA mutation carriers with Parkinson’s disease

T. Yousaf, M. Kershaw, V. Suarez Contreras, P. Vickers, G. Pagano, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Structural connectivity changes in G2019S-LRRK2 gene mutation carriers without manifest Parkinson’s disease

G. Pagano, P. Vickers, J. Schulz, H. Wilson, M. Politis (London, United Kingdom)

1:15pm-2:45pm: Structural imaging changes in hepatic and neurological Wilson disease

A. Patel, K. Nalamada, A. Vives-Rodriguez, D. Robakis, T. Constable, J. Arora, M. Schilsky, S. Tinaz (New Haven, CT, USA)

1:15pm-2:45pm: The Dutch Parkinson and Cognition study (DUPARC): Cognitive impairment and cholinergic innervation in de novo Parkinson’s Disease patients

S. Vander Zee, JM. Boertien, MJJ. Gerritsen, JM. Spikman, T. van Laar (Groningen, Netherlands)

1:15pm-2:45pm: The neural representations of the voice tremor spectrum

L. Xavier, K. Simonyan (Boston, MA, USA)

1:15pm-2:45pm: The radiofrequency (RF)-induced heating profile of an externalized, directional DBS lead using functional imaging sequences in an Intraoperative Magnetic Resonance Imaging Suite (IMRIS)

P. Bhattacharyya, S. Jones, M. Lowe, M. Deblock, A. Machado, K. Baker (Cleveland, OH, USA)

1:15pm-2:45pm: The right hemisphere inhibitory network in patients with asymmetrical Parkinson’s disease: An fMRI study

F. Lazoya, I. Obeso, R. Gonzales Redondo, F. Villagra, E. Luis, J. Obeso, M. Jahanshahi, M. Pastor (Pamplona, Spain)

1:15pm-2:45pm: The role of Synaptic vesicle protein 2A (SV2A) in patients with Parkinson’s disease dementia and Dementia with Lewy bodies: An in vivo [11C]UCB-J PET study

H. Wilson, G. Dervenoulas, G. Pagano, A. Chandra, F. Niccolini, M. Esposito, R. Gunn, L. Ricciardi, E. Rabiner, D. Aarsland, M. Politis (London, United Kingdom)

1:15pm-2:45pm: The Use of Diffusion Weighted Imaging to Detect Structural Biomarkers in Recently-Diagnosed Parkinson’s Disease Patients

P. Macdonald, N. Handfield-Jones, E. Alushaj, N. Hiebert, A. Owen, A. Khan (London, ON, Canada)

1:15pm-2:45pm: Tracking cortical changes throughout cognitive decline in Parkinson’s disease: a longitudinal MRI study

E. Canu, F. Agosta, T. Stojković, S.. Basaia, I. Stankovic, V. Markovic, I. Petrović, E. Stefanova, V. Kostic, M. Filippi (Milan, Italy)

1:15pm-2:45pm: Usefulness of Cardiac MIBG Scintigraphy, DAT scan and midbrain/pontine ratio to differentiate Parkinson disease from atypical parkinsonian syndrome

H. Fujita, K. Suzuki, Y. Watanabe, M. Hamaguchi, K. Hirata (Mibu, Japan)

1:15pm-2:45pm: Variations in Olfactory Neural Connections Associated with Cognition in Parkinson’s Disease

H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)

1:15pm-2:45pm: Visual assessment of dopamine transporter imaging in normal pressure hydrocephalus

KY. Kwon, H. Ju, K. Im, JY. Lee, MY. Ahn (Seoul, Republic of Korea)

1:15pm-2:45pm: Visual subnetwork dysfunction in Parkinson’s patients with primary visual hallucinations

S. Rane, A. Lenka, S. Prasad, J. Saini, M. Ingalhalikar, P. Pal (Seatle, WA, USA)

1:15pm-2:45pm: White matter abnormalities correlate with clinical features in PSP patients

A. Campabadal, A. Abos, B. Segura, HC. Baggio, C. Uribe, A. Garrido, A. Camara, E. Muñoz, F. Valldeoriola, MJ. Martí, C. Junqué, Y. Compta (Barcelona, Spain)

1:15pm-2:45pm: White matter and subcortical volume of essential tremor patient decreases after MR-guided focused ultrasound thalamotomy

K. Tsai, HC. Lai, CY. Wei, PY. Chiu, W. Lin, CL. Chen, SK. Yang, CH. Hung, WC. Chang (Changhua County, Taiwan)

1:15pm-2:45pm: Whole-Body Neuromuscular Ultrasound for Evaluating Posture and Targeted Management of Muscle Spasticity and Pain

R. Bubnov, L. Kalika (Kyiv, Ukraine)

« View all sessions from the 2019 International Congress.